A Randomized Phase II Clinical Trial on the Efficacy of Axitinib as a Monotherapy or in Combination With Lomustine for the Treatment of Patients With Recurrent Glioblastoma
Clinical trial NCT01562197 · COMPLETED
Trial details
- NCT number
- NCT01562197
- Sponsor
- Bart Neyns
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2018-08-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.